【摘要】 目的 觀察綜合治療體表血管瘤及脈管畸形的臨床療效。 方法 2008年1月-2010年9月，收治體表血管瘤和脈管畸形患者共205例。手術治療156例，其中單純手術治療103例，合并介入治療9例，硬化劑治療44例；非手術治療49例，其中介入治療1例，硬化劑治療38例，介入合并硬化劑治療10例。術后隨訪6個月～3年。 結果 15例手術治療患者于術后6個月～2年復發，其中單純手術治療患者10例（復發率9.71%），合并介入治療患者2例（復發率22.22%），合并硬化劑治療患者3例（復發率6.82%），均再次手術治療后痊愈。9例非手術治療患者于治療后3個月～2年復發，其中8例硬化劑治療患者，1例介入合并硬化劑治療患者，均經手術治療后痊愈。余患者未見復發。 結論 以手術治療為主的綜合治療，是體表血管瘤和脈管畸形治療的良好方法。
【Abstract】 Objective To observe the clinical therapeutic efficacy of comprehensive treatment on body surface hemangioma and vascular malformations. Methods Between January 2008 and September 2010, 205 pateints with surface hemangioma and vascular malformation were treated. A total of 156 patients received surgical treatment, in whom 103 received surgery alone, 9 underwent combined interventional treatment, and 44 received combined sclerotherapy. There were 49 patients underwent non-surgical treatment, including intervention in 1, sclerotherapy in 38 involving 10 had combined sclerotherapy. The patients were followed up for 6 months to 3 years. Results A total of 15 patients who had received surgical treatment recurred 6 months to 2 years after the treatment, including 10 who had been treated with surgery alone (with the recurrence rate of 9.71%), 2 combined with interventional treatment (with the recurrence rate of 22.22%), and 3 combined with sclerotherapy (with the recurrence rate of 6.82%). They were all cured after reoperation. Nine cases of non-surgical treatment recurred 3 months to 2 years after the treatment, including 8 who had received sclerotherapy, and 1 combined with interventional treatment and sclerotherapy. Patients were all cured after surgery. The other patients had no recurrence. Conclusion Applying mainly on surgical treatment, the combined therapy is a good way for body surface hemangioma and vascular malformations.
引用本文： 宋燁,田新立,許學文,岑瑛. 體表血管瘤和脈管畸形的綜合治療臨床觀察. 華西醫學, 2011, 26(10): 1449-1451. doi: 復制